Epirubicin 50mg
| Product Overview | |
| Generic Name | Epirubicin 50mg |
| Brand Name(s) | Ellence, Pharmorubicin, Papluf |
| Form | Intravenous solution for injection |
| Strength | 50 mg Vial |
| Therapeutic Class | Anthracycline antitumor antibiotic; topoisomerase II inhibitor |
| ATC Code | L01DB03 |
| Manufacturing & Regulatory | |
| Manufacturer | Pfizer, Ulsa Tech, Zurich |
| Country | Mexico, India, USA |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.1774.00 |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 Vials |
| Shelf Life | 24 Months |
| Storage | Store at 20–25 °C |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
Description
Epirubicin is an anthracycline chemotherapy used in oncology regimens; indicated as a component of adjuvant therapy for breast cancer with axillary node involvement
